Andrew Fedder

Andrew Fedder brings over a decade of legal experience to Scorpion Therapeutics. During the course of his career, he has advised on a wide array of complex business transactions in the pharmaceutical space, with a focus on acquisitions, divestitures and investments. Prior to joining Scorpion Therapeutics, Mr. Fedder worked at Bristol-Myers Squibb Company in increasing roles of responsibility, most recently acting as Assistant General Counsel for Corporate and Business Development and, previously, Senior Corporate Counsel for the company’s Mergers & Acquisitions team.